The Spin-off Panel provides potential investors, partners and licensees with an additional opportunity to learn about more advanced innovative projects and encourages entrepreneurs to present their businesses in a way that appeals to experienced decision makers from the biopharmaceutical industry. It combines a challenging Q&A session with a concise presentation and poster exhibition.
In 2016, eight start-up companies from the Czech Republic, Germany, Denmark, Luxembourg, and the Netherlands traveled to Munich to participate in the BioVaria Spin-off Panel. To kick-off the afternoon, each team competed for a BioVaria Spin-off Prize by pitching their start-up idea, followed by a short Q&A session in front of the audience and judges. An intense speed-dating session followed the pitches, with all eight spin-off teams meeting individually with eight international venture capital and angel investors.
The Spin-off from the Charité convinced the selection committee comprised of seasoned investors with their business pitch and was awarded the BioVaria Jury Prize (EUR 1,000 and one conference pass to the 16th Annual Biotech in Europe Forum for Global Partnering & Investment organized by Sachs Associates), while due to popular vote Braingineering Technologies took home the BioVaria Audience Prize (one conference pass to the 16th Annual Biotech in Europe Forum for Global Partnering & Investment).
Dr Filippo Bosco, Dr Robert Burger, Dr Marco Donolato
Dr Stephanie Smith-Eckhardt, Prof. Jens Schwamborn, Dr Silvia Bolognin
Prof. Martin Fusek, Tim Dyer, Dr Roman Dvorak, Dr Sonia Poli
Dr Nuno Viegas
Sivakumar Bactavatchalou, Dr Pranjul Shah